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doi:10.1016/j.ejvs.2010.12.022Abstract Objectives: The treatment guidelines for isolated superior mesenteric artery
dissection (SMAD) are not well established. The purpose of this study was to report a single-
centre series of SMAD and propose treatment guidelines.
Materials and Methods: Between November 2004 and December 2009, 30 patients were diag-
nosed with SMAD. We retrospectively reviewed their medical records.
Results: The subjects included 26 men and four women, with a mean age of 55.1 years. The
chief complaint was abdominal pain in 17 patients, whereas 13 patients were asymptomatic.
The mean follow-up was 38.3 months. The radiographic findings included intimal flap with
a false lumen in 20 patients and intramural haematoma in 10 patients. The treatments
included observation in 18 patients, anticoagulation in five patients, stenting in six patients
and surgery in one patient. During follow-up (mean 15.6 months), there was no change in
the computed tomography scans of seven patients, improvement was observed in four patients
and complete resolution was observed in four patients. All patients, including the symptomatic
patients, remained asymptomatic during follow-up.
Conclusions: Most patients with SMAD can be successfully managed with conservative treat-
ment. Surgical treatment or percutaneous intervention can be reserved for patients with
severe mesenteric ischaemia and those for whom the initial conservative treatment fails.
ª 2011 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.2 611 3058; fax: þ82 42 259 1125.
r (B.S. Cho).
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Table 1 Patients characteristics.
Male:female 26:4
Mean age (years) 5511 (38e74)
Mean follow-up
Period (months) 3814 (4e62)
Chief complaints (numbers)
Diagnosed incidentally 13
Symptomatic 17
Comorbidity
Hypertension 9
DM 1
Angina 1
Treatment Guidelines for Isolated Dissection of the SMA 781Isolated superior mesenteric artery dissection (SMAD) is
a rare disorder, and only 106 cases were detected with
a MEDLINE literature search.1 The aetiology, pathophysi-
ology and proper treatment of SMAD are not yet clear. The
current proposed treatment guidelines provide an algo-
rithm based on the indication for surgery, the abdominal
symptoms, the presence of an intimal flap and the length of
a stenosis.2e4 Because there are no definite treatment
guidelines, patients with SMAD have been treated according
to their anatomical status, their co-morbidities and the
preferences of their physicians.
We undertook this study to devise appropriate treatment
guidelines for the treatment of isolated SMAD based on
follow-up computed tomography (CT) findings and the
clinical course of the disease.
Patients and Methods
This study included 30 patients who were diagnosed with
isolated SMAD at our hospital between November 2004 and
December 2009. Patients with isolated SMAD were identified
by searching the medical records for SMAD, acute or chronic
vascular disorder of intestines and aortic dissection at our
Department of Health Information Management. Their
medical and imaging records were reviewed retrospectively.
The changes in the patients’ images on CT scans and their
responses to different treatment modalities were analysed.
If a patient had another artery involvement, such as an aortic
dissection, that patient was excluded from the study.
When isolated SMAD was detected incidentally during
the work-up for another treatment, we simply observed the
patient because these patients had no SMAD-associated
abdominal pain or luminal stenosis on a CT scan. When
isolated SMAD was detected during the investigation of
abdominal pain and there was no indication for surgical
repair, such as bowel necrosis or arterial rupture, then we
selectively performed observational, anticoagulation or
endovascular treatment, according to the severity of the
pain, the degree of leucocytosis and the results of a phys-
ical examination of the patient and the CT findings, such as
the degree of luminal stenosis.
The statistical analysis was performed with SPSS version
13.0 (SPSS Inc., Chicago, IL, USA). The association between
abdominal pain and intravascular stenosis was confirmed
with a c2 test. A p value of <0.05 was considered statisti-
cally significant.
Results
Thirty patients (26 men and four women) were diagnosed
with SMAD during the study period. Their mean age was
55  11 years (range, 38e74 years). Thirteen cases were
detected incidentally, without symptoms, and 17 cases
were detected because of abdominal pain. The mean
follow-up period was 38  14 months (range, 4e62 months).
Hypertension was detected in nine patients, diabetes
mellitus in one patient and angina in one patient (Table 1).
The dissection started at a mean distance of 22  11 mm
(range, 5e46 mm) from the origin of the SMA and had
a mean length of 48  30 mm (range, 10e150 mm), as
measured on CT scans.A CT scan was performed on the first, third and sixth
month after the first presentation and every six months
thereafter. The indications for the termination of follow-up
were no recurrence of abdominal pain, no increase in the
size of the aneurysmal sac and less than 50% stenosis. The CT
findings could be categorised into two types: (1) double
lumen with an intimal flap, with a patent or closed false
lumen and (2) intramural haematoma based on the imaging
features, and this was further subcategorised according to
the presence/absence of stenosis (Figs. 1e3). Among the
asymptomatic patients detected incidentally, a patent false
lumen with an intimal flap was detected in 12 patients, and
an intramural haematoma was detected in one patient.
There was no stenosis in any asymptomatic patient. Among
the symptomatic group, a patent false lumenwith an intimal
flap was found in two patients, a closed false lumen with an
intimal flap was found in six patients and an intramural
haematoma was found in nine patients. Among the 17
symptomatic patients, vascular stenosis was observed in 15
patients, and there was no stenosis in two patients. The
correlation between stenosis and abdominal pain was
statistically significant (pZ 0.002; Table 2).
Fifteen of 23 patients underwent follow-up CT scanning.
Seven of the original 30 patients who underwent stenting or
surgery were excluded from follow-up because their
underlying problems had been corrected. The purpose of
this follow-up CT scanning was to determine the natural
process of SMAD and to examine the changes that occurred
in the CT images. Five asymptomatic patients and 10
symptomatic patients underwent CT scans. The mean
follow-up period was 16  16 months (range, 2e45 months).
There were no changes on the CT scans of seven patients,
improved stenosis or reduced aneurysm size on those of
four patients and complete resolution on those of four
patients. Interestingly, no change during the follow-up was
detected in seven of the 11 patients with a double lumen
combined with an intimal flap, and complete resolution was
detected in only those patients with an intramural hae-
matoma (Table 3; Fig. 4). Aneurysmal change on a CT scan
was detected in 17 of the 20 patients with a double lumen,
and in two of the 10 patients with an intramural haema-
toma. There was no increase in the aneurysm size or
aneurysm rupture in any patient who underwent CT scan-
ning during follow-up.
Figure 1 Classification of CT finding. (A) Figure shows double lumen with patent false lumen without stenosis, (B) figure shows
double lumen with closed false lumen and stenosis, (C) figure shows intramural haematoma without stenosis, (D) figure shows
intramural hematoma with stenosis.
782 B.S. Cho et al.The 13 incidentally diagnosed patients were treated
with observational management (expectant management),
but in one patient, endovascular stenting was performed as
an adjunct procedure with carotid angiography. Among the
17 symptomatic patients, observational management was
the primary treatment for six patients, five were managed
conservatively with anticoagulant, five were treated with
endovascular stenting and one patient was treated with
surgery because of apparent bowel necrosis. No additional
procedure was required by any patient. There was no
recurrence of symptoms in any patient during the follow-up
period.
Discussion
The number of patients diagnosed with isolated SMAD has
been increasing because the use of CT to diagnose gastro-
intestinal disease has increased.5 A few recent reports have
proposed treatment guidelines or treatment algorithms
based on literature reviews or analyses of other reports.2,3Figure 2 Incidental finding. (A) SMA has intramural thrombosis w
proximal SMA.The present study was retrospective but examined
a large number of patients diagnosed at a single institution.
We investigated the early to mid-term results of SMAD
treatment, so it is limited in terms of long-term results.
The categorisation of isolated SMAD according to
imaging features has been attempted in several reports.
Suzuki et al.6 categorised SMAD into four types based on CT
findings: an intimal flap, haematoma of the false lumen or
intramural haematoma, an enlarged SMA diameter and
increased attenuation of the fat surrounding the SMA. They
suggested that the increased attenuation of the fat was an
early diagnostic finding. However, in our study, there was
no increased attenuation of the fat around the SMA.
Sakamoto et al.4 categorised SMAD into four types
depending on the CT imaging features: type I involved
a patent false lumen with both entry and re-entry; type II
involved a ‘cul-de-sac’-shaped false lumen without re-
entry; type III involved a thrombosed false lumen with an
ulcer-like projection; and type IV involved a completely
thrombosed false lumen with an ulcer-like projection. Theyithout stenosis, (B) double lumen with intimal flap begins from
Figure 3 CT findings of symptomatic patient. (A) CT scan shows intramural thrombosis and stenosis, (B) SMA has double lumen
with patent false lumen without stenosis, (C) double lumen with closed false lumen and stenosis is present on the CT scan.
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according to the disease type: conservative management
for types I and IV but long-term follow-up for types II and III
because bowel necrosis or rupture is possible.
In most of our patients with SMAD that involved a patent
false lumen, the lumen did not change in size during the
follow-up period, as also reported by Sakamoto et al.,4
except in one patient who had improved features on the
follow-up CT scan. However, among the five patients with
an intramural haematoma, four showed complete resolu-
tion on their follow-up CT scans, whereas the CT findings of
one patient remained unchanged. There were no ulcer-like
projections in the thrombosed false lumens on our CT scans,
as were reported by Sakamoto et al.4
The treatments reported so far can be classified into
four types: (1) observation, (2) conservative treatment with
an anticoagulant, (3) endovascular therapy and (4) surgery.
Yasuhara et al.7 reported successful experiences with
observational management if there was no sign of bowel
necrosis. Successful observational management without
anticoagulation has been reported by many other
authors.1,2,8,9 In our study, all of the patients in the inci-
dental group and six symptomatic patients were success-
fully treated with observational management.Table 2 CT findings (numbers, 30).
Incidental
group (13)
Symptomatic
group (17)
Double lumen 12 8
with intimal flap
Patent false lumen 12 2
Closed false lumen 0 6
Intramural thrombosis 1 9
Stenosisa 0 15
No stenosis 13 2 pZ0.002
a Reduction of diameter < 50%.Conservative management with anticoagulation for iso-
lated SMAD was first reported by Ambo et al. in 1994.10
Since then, successful treatment with this method has
been reported.2,4,9,11 The rationale for this treatment is to
prevent further haematoma of the stenotic segment and
distal embolisation. In this manner, we successfully treated
five patients.
The first surgical treatment of SMAD was described by
Sisteron and Vieville in 1975.12 Numerous procedures for its
surgical management have been described, including
thrombectomy, endoaneurysmorrhaphy, intimectomy and
patch angioplasty, resection, venous bypass graft and
arterial bypass graft.2 Until recently, surgical treatments,
including small-bowel transplantation, have been sporadi-
cally reported.2,13 However, endovascular therapy for iso-
lated SMAD is a less-invasive alternative to open surgical
repair, and if there is no absolute indication for surgery,
such as arterial rupture or bowel necrosis, then endovas-
cular therapy is the preferred initial treatment.
Leung et al.14 used stent placement for the first time in
2000. Since then, endovascular therapy has become
a successful intervention for the treatment of isolated
SMAD.1,15e17 We also performed successful endovascular
stenting in five patients, without complications. Gobble
et al.1 reported endovascular therapy performed as
a secondary procedure. One of three patients treated withTable 3 Follow-up CT findings (15 patients).
Findings Asymptomatic
group (5)
Symptomatic
group (10)
No change 4a 3a
Improvement (stenosis,
aneurysm size)
4
Complete resolution 1b 3b
a Double lumen with a intimal flap on CT scan except one
patient.
b Intramural thrombosis on CT scan.
Figure 4 Findings of follow-up CT scan. (A) This shows complete resolution of the intramural hematoma. (B) Double lumen with
a closed false lumen and intramural thrombosis changed to a patent false lumen without stenosis. This also shows decrease of
aneurysmal change.
784 B.S. Cho et al.anticoagulation had persistent abdominal pain and was
successfully treated with endovascular therapy.
Recently, some authors have proposed treatment guide-
lines or algorithms for isolated SMAD based on literature
reviews and the analysis of other reports. Morris et al.2Figure 5 Proposed guideline for the treatmeproposed that patients with isolated SMAD should undergo
surgery when arterial rupture occurs or when bowel necrosis
is apparent on a CT scan. If patients are not surgical candi-
dates, then either conservative management or endovas-
cular therapy can be selected based on the presence of annt of superior mesenteric artery dissection.
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suggests that it is appropriate to recommend conservative
management with anticoagulation as the primary therapy. If
this primary therapy fails, then endovascular therapy might
be a good choice. Subhas et al.3 recommended diagnostic
laparoscopy rather than open surgery if bowel necrosis were
suspected. They also reported that the length of the dis-
sected segment, symptoms and aneurysmal changes were
important factors for consideration when the treatment
modality is selected. However, in our study, these factors
were not important when the treatment modality was
selected when the distal blood flow was not disturbed.
Based on our study and a literature review, we propose
treatment guidelines for isolated SMAD (Fig. 5). When iso-
lated SMAD is detected incidentally, observational
management is sufficient. In symptomatic patients, if there
is no surgical indication, such as arterial rupture or bowel
necrosis, conservative management with anticoagulation
can be performed initially. If conservative management
fails, then endovascular therapy is the treatment of choice.
Conclusion
Because the use of CT scans for imaging and diagnosing
abdominal pathologies is increasing, the incidence of iso-
lated SMAD has also increased. However, no treatment
guidelines for isolated SMAD have yet been established. In
our study, all the patients with isolated SMAD were
successfully treated, with no morbidity or mortality. If no
bowel necrosis or other surgical complication is evident,
then observational management or anticoagulation might
be a good choice. Endovascular therapy has a role as
a primary or secondary treatment. A further prospective
study with long-term follow-up is necessary to establish the
appropriate treatment guidelines for isolated SMAD.
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